Table 3.
Retrograde | Anterograde | |||||||
---|---|---|---|---|---|---|---|---|
Parameter | r | OR | 95% CI | pvalue | r | OR | 95% CI | pvalue |
Age | –0.0330 | -- | –0.2377/0.1744 | 0.7490 | 0.0300 | -- | –0.2307/0.1731 | 0.7668 |
PSA | 0.2575 | -- | 0.1025/0.4040 | 0.0036 | 0.3121 | -- | 0.1163/0.4845 | 0.0017 |
Prostate volume | 0.2015 | -- | 0.1052/0.3174 | 0.0108 | 0.0636 | -- | –0.1403/0.2623 | 0.5296 |
Pathological stage | 0.3167 | -- | 0.1224/0.4876 | 0.0013 | 0.5703 | 0.4161/0.6926 | <0.0001 | |
pT2 | 1.0 | 1.0 | ||||||
pT3 | 1.40 | 1.10– 2.25 | 0.0010 | 1.80 | 1.30–2.60 | 0.0001 | ||
Gleason score | 0.0523 | –0.1514/0.2518 | 0.6053 | –0.0107 | –0.2124/0.1918 | 0.7155 | ||
≤ 7 (3+4) | 1.0 | 1.0 | ||||||
≥ 7 (4+3) | 1.05 | 0.93– 1.12 | 0.6140 | 1.02 | 0.92–1.10 | 0.6530 | ||
Seminal vesicles | 0.2508 | 0.0512/0.4311 | 0.0118 | 0.2219 | 0.0313/0.3615 | 0.0272 | ||
Negative | 1.0 | 1.0 | ||||||
Positive | 1.45 | 1.10– 2.35 | 0.0120 | 1.36 | 1.05– 2.15 | 0.0254 | ||
Lymphonode status | –0.0824 | –0.2799/0.1217 | 0.4151 | –0.0709 | –0.2692/0.1331 | 0.4830 | ||
N− | 1.0 | 1.0 | ||||||
N+ | 1.04 | 0.92– 1.09 | 0.5050 | 1.04 | 0.93–1.11 | 0.5130 | ||
Nerve sparing | 0.0293 | –0.1738/0.2301 | 0.5722 | 0.0471 | –0.1565/0.2469 | 0.5415 | ||
No nerve sparing | 1.0 | 1.0 | ||||||
Unilateral | 1.20 | 1.0–1.300.92– | 0.0430 | 1.25 | 1.0–1.38 | 0.0390 | ||
Bilateral | 1.02 | 1.10 | 0.6830 | 1.04 | 0.94–1.15 | 0.6513 |
r = Spearman coefficient; OR = odds ratio; 95% CI = 95% confidence interval; PSA = prostate-specific antigen.
Note: These results are employing the Spearman coefficients, logistic and univariate analysis).